Literature DB >> 22157092

APOBEC3 proteins and genomic stability: the high cost of a good defense.

Iñigo Narvaiza1, Sébastien Landry, Matthew D Weitzman.   

Abstract

The human APOBEC3 family of cytidine deaminases constitutes a cellular intrinsic defense mechanism that is effective against a range of viruses and retro-elements. While it is well established that these enzymes are powerful mutators of viral DNA, the possibility that their activity could threaten the integrity of the host genome has only recently begun to be investigated. Here, we discuss the implications of new evidence suggesting that APOBEC3 proteins can mediate the deamination of cellular DNA. The maintenance of genomic integrity in the face of this potential off-target activity must require high fidelity DNA repair and strict regulation of APOBEC3 gene expression and enzyme activity. Conversely, the ability of specific members of the APOBEC3 family to activate DNA damage signaling pathways might also reflect another way that these proteins contribute to the host immune response.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22157092      PMCID: PMC3272230          DOI: 10.4161/cc.11.1.18706

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  105 in total

Review 1.  Functions and regulation of the APOBEC family of proteins.

Authors:  Harold C Smith; Ryan P Bennett; Ayse Kizilyer; William M McDougall; Kimberly M Prohaska
Journal:  Semin Cell Dev Biol       Date:  2011-10-06       Impact factor: 7.727

Review 2.  Interactions between DNA damage, repair, and transcription.

Authors:  Andriy Khobta; Bernd Epe
Journal:  Mutat Res       Date:  2011-08-12       Impact factor: 2.433

3.  APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis.

Authors:  Qingqing Ding; Chun-Ju Chang; Xiaoming Xie; Weiya Xia; Jer-Yen Yang; Shao-Chun Wang; Yan Wang; Jiahong Xia; Libo Chen; Changchun Cai; Huabin Li; Chia-Jui Yen; Hsu-Ping Kuo; Dung-Fang Lee; Jingyu Lang; Longfei Huo; Xiaoyun Cheng; Yun-Ju Chen; Chia-Wei Li; Long-Bin Jeng; Jennifer L Hsu; Long-Yuan Li; Alai Tan; Steven A Curley; Lee M Ellis; Raymond N Dubois; Mien-Chie Hung
Journal:  J Clin Invest       Date:  2011-10-10       Impact factor: 14.808

Review 4.  Preventing AID, a physiological mutator, from deleterious activation: regulation of the genomic instability that is associated with antibody diversity.

Authors:  Hitoshi Nagaoka; Thinh Huy Tran; Maki Kobayashi; Masatoshi Aida; Tasuku Honjo
Journal:  Int Immunol       Date:  2010-03-05       Impact factor: 4.823

5.  Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA.

Authors:  A Mehta; M T Kinter; N E Sherman; D M Driscoll
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

6.  Purification and molecular cloning of a novel essential component of the apolipoprotein B mRNA editing enzyme-complex.

Authors:  H Lellek; R Kirsten; I Diehl; F Apostel; F Buck; J Greeve
Journal:  J Biol Chem       Date:  2000-06-30       Impact factor: 5.157

Review 7.  Diverse functions for DNA and RNA editing in the immune system.

Authors:  Claire E Hamilton; F Nina Papavasiliou; Brad R Rosenberg
Journal:  RNA Biol       Date:  2010-03-29       Impact factor: 4.652

Review 8.  Role of activation-induced cytidine deaminase in inflammation-associated cancer development.

Authors:  Hiroyuki Marusawa; Atsushi Takai; Tsutomu Chiba
Journal:  Adv Immunol       Date:  2011       Impact factor: 3.543

9.  The antiviral factor APOBEC3G enhances the recognition of HIV-infected primary T cells by natural killer cells.

Authors:  Jason M Norman; Michael Mashiba; Lucy A McNamara; Adewunmi Onafuwa-Nuga; Estelle Chiari-Fort; Wenwen Shen; Kathleen L Collins
Journal:  Nat Immunol       Date:  2011-08-28       Impact factor: 25.606

10.  APOBEC3A is a specific inhibitor of the early phases of HIV-1 infection in myeloid cells.

Authors:  Gregory Berger; Stéphanie Durand; Guillaume Fargier; Xuan-Nhi Nguyen; Stéphanie Cordeil; Serge Bouaziz; Delphine Muriaux; Jean-Luc Darlix; Andrea Cimarelli
Journal:  PLoS Pathog       Date:  2011-09-22       Impact factor: 6.823

View more
  12 in total

1.  APOBEC3A damages the cellular genome during DNA replication.

Authors:  Abby M Green; Sébastien Landry; Konstantin Budagyan; Daphne C Avgousti; Sophia Shalhout; Ashok S Bhagwat; Matthew D Weitzman
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

2.  Cytidine deaminase Apobec3a induction in fallopian epithelium after exposure to follicular fluid.

Authors:  Pavla Brachova; Nehemiah S Alvarez; Bradley J Van Voorhis; Lane K Christenson
Journal:  Gynecol Oncol       Date:  2017-02-16       Impact factor: 5.482

3.  Avoidance of APOBEC3B-induced mutation by error-free lesion bypass.

Authors:  James I Hoopes; Amber L Hughes; Lauren A Hobson; Luis M Cortez; Alexander J Brown; Steven A Roberts
Journal:  Nucleic Acids Res       Date:  2017-05-19       Impact factor: 16.971

4.  APOBEC3 cytidine deaminases in double-strand DNA break repair and cancer promotion.

Authors:  Roni Nowarski; Moshe Kotler
Journal:  Cancer Res       Date:  2013-04-18       Impact factor: 12.701

5.  APOBEC3A and APOBEC3B Preferentially Deaminate the Lagging Strand Template during DNA Replication.

Authors:  James I Hoopes; Luis M Cortez; Tony M Mertz; Ewa P Malc; Piotr A Mieczkowski; Steven A Roberts
Journal:  Cell Rep       Date:  2016-01-28       Impact factor: 9.423

6.  Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma.

Authors:  Niels Weinhold; Cody Ashby; Leo Rasche; Shweta S Chavan; Caleb Stein; Owen W Stephens; Ruslana Tytarenko; Michael A Bauer; Tobias Meissner; Shayu Deshpande; Purvi H Patel; Timea Buzder; Gabor Molnar; Erich A Peterson; Frits van Rhee; Maurizio Zangari; Sharmilan Thanendrarajan; Carolina Schinke; Erming Tian; Joshua Epstein; Bart Barlogie; Faith E Davies; Christoph J Heuck; Brian A Walker; Gareth J Morgan
Journal:  Blood       Date:  2016-08-11       Impact factor: 22.113

7.  Construction and characterization of an infectious replication competent clone of porcine endogenous retrovirus from Chinese miniature pigs.

Authors:  Silong Xiang; Yuyuan Ma; Qipo Yan; Maomin Lv; Xiong Zhao; Huiqiong Yin; Nian Zhang; Junting Jia; Rong Yu; Jingang Zhang
Journal:  Virol J       Date:  2013-07-09       Impact factor: 4.099

8.  Interaction of APOBEC3A with DNA assessed by atomic force microscopy.

Authors:  Luda S Shlyakhtenko; Alexander J Lushnikov; Ming Li; Reuben S Harris; Yuri L Lyubchenko
Journal:  PLoS One       Date:  2014-06-06       Impact factor: 3.240

9.  APOBEC3A deaminates transiently exposed single-strand DNA during LINE-1 retrotransposition.

Authors:  Sandra R Richardson; Iñigo Narvaiza; Randy A Planegger; Matthew D Weitzman; John V Moran
Journal:  Elife       Date:  2014-04-24       Impact factor: 8.140

10.  USP49 potently stabilizes APOBEC3G protein by removing ubiquitin and inhibits HIV-1 replication.

Authors:  Ting Pan; Zheng Song; Liyang Wu; Guangyan Liu; Xiancai Ma; Zhilin Peng; Mo Zhou; Liting Liang; Bingfeng Liu; Jun Liu; Junsong Zhang; Xuanhong Zhang; Ryan Huang; Jiacong Zhao; Yonghong Li; Xuemei Ling; Yuewen Luo; Xiaoping Tang; Weiping Cai; Kai Deng; Linghua Li; Hui Zhang
Journal:  Elife       Date:  2019-08-09       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.